Search
Search Constraints
You searched for: Author/Creator Ellison, CorieLimit your search
- Ellison, Corie [remove] 10
- Toxicology -- Periodicals 10
- 615.9005 4
- 363.179 3
- 615.9 3
- Environmentally induced diseases -- Periodicals 3
- Industrial toxicology -- Periodicals 3
- Toxicity testing -- In vitro -- Periodicals 2
- ADME Absorption, Metabolism, Distribution and Excretion -- ANSA Agencies Network on Scientific Advice -- AOP Adverse Outcome Pathway -- AR Androgen Receptor -- AUC Area Under the Curve -- CC Cramer Class -- Cmax Maximal blood Concentration -- CMR Carcinogen, Mutagen, Reproductive toxic -- Css Blood concentration at steady-state -- DB Data Base -- EAR Exposure: Activity Ratio -- ER Estrogenic Receptor -- ECHA European Chemicals Agency -- EFSA European Food Safety Authority -- EMA European Medicines Agency -- EPA Environmental Protection Agency -- GI Gastro-Intestinal -- HBA Hydroxy Benzoic Acid -- hERG human Ether-à-go-go Related Gene -- IATA Integrated Approaches to Testing and Assessment -- IC Inhibitory Concentration -- ICCR International Cooperation on Cosmetics Regulation -- IRIS Integrated Risk Information System -- IVIVE Vitro to in vivo Extrapolation -- JRC Joint Research Centre -- LOAEL Lowest Observed Adverse Effect Level -- LRSS Long Range Science Strategy -- MIE Molecular Initiating Event -- MoA Mode of Action -- MoS Margin of Safety -- MOIE Margin Of Internal Exposure -- NAM New Approach Methodology -- NGRA Next Generation Risk Assessment -- NOAEL No Observed Adverse Effect Level -- NOEL No Observed Effect Level -- NOTEL No Observed Transcriptional Effect Level -- OECD Organisation for Economic Cooperation and Development -- PBK Physiologically Based Kinetics -- PBT Persistent, Bioaccumulative, Toxic -- PBPK Physiologically Based Pharmaco Kinetics -- PBTK Physiologically Based Toxico Kinetics -- PCA Principal Component Analysis -- PK Pharmacokinetic -- POD Point Of Departure -- PTD Para Toluene Diamine -- PPD Para Phenylene Diamine -- (Q)SAR (Quantitative) Structure-Activity Relationship -- RIFM Research Institute of Fragrance Materials -- 3Rs Replacement, Reduction, Refinement (Principle of Russell and Burch) -- SAR Structure Activity Relationship -- SCCS Scientific Committee on Consumer Safety -- SED Systemic Exposure Dose -- SCHEER Scientific Committee on Health, Environmental and Emerging Risks -- THR Thyroid Hormone Receptor -- (i)TTC (internal) Threshold of Toxicological Concern -- UBA German Environmental Agency -- US EPA US Environmental Protection Agency -- WHO World Health Organization -- WoE Weight of Evidence 1
- ADME absorption, distribution, metabolism, elimination -- AOP adverse outcome pathway -- EFSA European Food and Safety Agency -- EURL ECVAM European Union Reference Laboratory for Alternatives to Animal Testing -- FDA US Food and Drug Administration -- IATA Integrated Approaches to Testing and Assessment -- LRSS Long Range Science Strategy -- MoA mode of action -- NOTEL no observed transcriptomic adverse effect level -- OECD Organisation for Economic Cooperation and Development -- PBPK Physiologically based pharmacokinetics -- PoD point of departure -- SEURAT-1 Safety Evaluation Ultimately Replacing Animal Test programme -- QIVIVE quantitative in vitro-in vivo extrapolation -- US EPA US Environmental Protection Agency -- TD toxicodynamics -- TK toxicokinetics -- TTC threshold of toxicological concern -- iTTC internal threshold of toxicological concern -- TRV toxicological reference value 1
- Chemicals -- Physiological effect -- Periodicals 1